RSV recommendations & preventatives for Fall 2024
Corewell HealthCorewell Health physicians offer expert advice on RSV and how to prevent serious illness this fall and winter. https://vimeo.com/1014594403/a43d6d1676?share=copy
Corewell Health physicians offer expert advice on RSV and how to prevent serious illness this fall and winter. https://vimeo.com/1014594403/a43d6d1676?share=copy
The liver transplant program at Corewell Health in Southeast Michigan consistently ranks among the highest quality liver transplant programs in Michigan and the nation, according to federal quality data.
Fall is here and with it, comes cold and flu season. With schools back in session and people gathering inside more, COVID will also be a player in this year’s circulating respiratory viruses. Corewell Health’s infectious disease experts Dr. Russ Lampen and Dr. Nick Gilpin teamed up to answer the most frequently asked questions when it comes to this year’s COVID vaccine. You can download an edited package HERE: https://vimeo.com/1009923626/8089770e92?share=copy Or, put together your own story using raw footage HERE: https://vimeo.com/1010598326/33c7177fc1?share=copy Thank you for your consideration. Please feel free to reach out with any questions.
For the past three years, Corewell Health researchers have been studying the genetic code of the virus that causes COVID-19 to better understand how it is changing and how to avoid another pandemic. Much of the world’s focus has been on the development of vaccines to prevent the spread of the virus; however, vaccines primarily target the portion of the virus that constantly changes, requiring vaccines to be regularly updated.
Corewell Health™ and Michigan State University researchers are the first in the state to use de-identified electronic health records of more than 1.5 million patients to analyze incidence rates and risk factors of mild cognitive impairment, or MCI, in rural and urban areas in West Michigan.
New Corewell Health™ research suggests an MRI scan can help predict whether patients with intermediate-risk prostate cancer (cancer confined to the entire prostate) may have more aggressive cancer in five years.
Corewell Health is working with Johns Hopkins Bloomberg School of Public Health and North Carolina Agricultural and Technical State University to learn more about the multi-level risk and biopsychosocial factors that contribute to Alzheimer’s disease in Black Americans, leading to the development of effective, tailored behavioral and pharmacological interventions aimed at reducing the condition’s disparate attack.